BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Vrije Universiteit Amsterdam//NONSGML v1.0//EN
NAME:Inaugural lecture prof.dr. K.H.N. de Boer
METHOD:PUBLISH
BEGIN:VEVENT
DTSTART:20260109T154500
DTEND:20260109T171500
DTSTAMP:20260109T154500
UID:inaugural-lecture-prof-dr-k-h-@8F96275E-9F55-4B3F-A143-836282E12573
CREATED:20260922T115220
LOCATION:Main building VU, 1105, Aula, De Boelelaan, 1081 HV, Amsterdam
SUMMARY:Inaugural lecture prof.dr. K.H.N. de Boer
X-ALT-DESC;FMTTYPE=text/html: <html> <body> <p><p>Amazing drug discove
 ries: het onderste uit de kan</p></p> <p>To provide affordable and hi
 gh-quality care to patients with inflammatory bowel disease (IBD), bo
 th in the Netherlands and abroad, now and in the future, we must appr
 oach this care from an efficiency perspective. Only then will costs a
 nd environmental impact become integral factors in the choice of a sp
 ecific medication. And once a well-balanced medication choice has bee
 n made, treatment must be optimized to maximize its potential. This i
 s what gastroenterologist Nanne de Boer says in his inaugural lecture
 .</p><p>"At the same time, we must focus on expanding the treatment a
 rsenal, because unfortunately, medications don't work for everyone. W
 e need to embrace drug rediscovery - the practice of giving a medicat
 ion for a completely different indication - more as this is a cost-ef
 fective and rapid method for new medication development," says De Boe
 r.</p> </body> </html>
DESCRIPTION: Amazing drug discoveries: het onderste uit de kan To prov
 ide affordable and high-quality care to patients with inflammatory bo
 wel disease (IBD), both in the Netherlands and abroad, now and in the
  future, we must approach this care from an efficiency perspective. O
 nly then will costs and environmental impact become integral factors 
 in the choice of a specific medication. And once a well-balanced medi
 cation choice has been made, treatment must be optimized to maximize 
 its potential. This is what gastroenterologist Nanne de Boer says in 
 his inaugural lecture."At the same time, we must focus on expanding t
 he treatment arsenal, because unfortunately, medications don't work f
 or everyone. We need to embrace drug rediscovery - the practice of gi
 ving a medication for a completely different indication - more as thi
 s is a cost-effective and rapid method for new medication development
 ," says De Boer.
END:VEVENT
END:VCALENDAR
